| Record ID | marc_records_scriblio_net/part22.dat:9924954:1047 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part22.dat:9924954:1047?format=raw |
LEADER: 01047pam 2200313 a 4500
001 91020144
003 DLC
005 19920106143226.7
008 910531s1991 nyua b 001 0 eng c
010 $a 91020144
020 $a0824784847 (alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 10 $aRM301.45$b.P454 1991
060 $aW1 DR893B v. 48$aQV 38 P5315
082 00 $a615.5/8$220
245 00 $aPharmaceutical bioequivalence /$cedited by Peter G. Welling, Francis L.S. Tse, Shrikant V. Dighe.
260 0 $aNew York :$bDekker,$cc1991.
300 $aix, 467 p. ;$bill. ;$c23 cm.
440 0 $aDrugs and the pharmaceutical sciences ;$vv. 48
504 $aIncludes bibliographical references and index.
650 0 $aDrugs$xTherapeutic equivalency.
650 0 $aDrugs$xBioavailability.
650 2 $aBiological Availability.
650 2 $aDrug Evaluation.
650 2 $aDrugs$xadministration & dosage.
650 2 $aTherapeutic Equivalency.
700 10 $aWelling, Peter G.
700 10 $aTse, Francis L. S.
700 10 $aDighe, Shrikant V.